Parkinson's Disease Research Today is a free monthly online journal that collates and summarizes the latest research about Parkinson's Disease, including details on symptoms, treatment, genetics, medication.

Volume 5 (2008), Issue 4 (April)

1. Bilateral subthalamic stimulation in Parkin and PINK1 parkinsonism.
   Neurology, 70(14): 1186-91. [Abstract] [Full-text]
2. The assessment of depression in Parkinson's disease.
   Eur J Neurol, 15(5): 487-92. [Abstract] [Full-text]
3. Relationship between weight, levodopa and dyskinesia: the significance of levodopa dose per kilogram body weight.
   Eur J Neurol, 15(5): 493-6. [Abstract] [Full-text]
4. Impact of fatigue on quality of life in patients with Parkinson's disease.
   Eur J Neurol, 15(5): 475-80. [Abstract] [Full-text]
5. Genetic variability of histamine receptors in patients with Parkinson's disease.
   BMC Med Genet, 9: 15. [Abstract] [Full-text]
6. Depressive illness in Parkinson's disease--indication of a more advanced and widespread neurodegenerative process?
   Acta Neurol Scand, 117(5): 295-304. [Abstract] [Full-text]
7. Effect of memantine on CBF and CMRO2 in patients with early Parkinson's disease.
   Acta Neurol Scand, 117(5): 317-23. [Abstract] [Full-text]
8. Induction of parkinsonian resting tremor by stimulation of the caudal zona incerta nucleus: a clinical study.
   J Neurol Neurosurg Psychiatry, 79(5): 514-21. [Abstract] [Full-text]
9. The utility of the Cambridge Behavioural Inventory in neurodegenerative disease.
   J Neurol Neurosurg Psychiatry, 79(5): 500-3. [Abstract] [Full-text]
10. Effects of subthalamic deep brain stimulation on dysarthrophonia in Parkinson's disease.
    J Neurol Neurosurg Psychiatry, 79(5): 522-9. [Abstract] [Full-text]
11. Functional imaging in Parkinson disease.
    Neurology, 70(16): 1478-88. [Abstract] [Full-text]
12. Subthalamic nucleus stimulation modulates audiospinal reactions in Parkinson disease.
    Neurology, 70(16): 1445-51. [Abstract] [Full-text]
13. Effects of subthalamic nucleus stimulation and levodopa on freezing of gait in Parkinson disease.
    Neurology, 70(16): 1431-7. [Abstract] [Full-text]
14. Parkinson disease and risk of mortality: a prospective comorbidity-matched cohort study.
    Neurology, 70(16): 1423-30. [Abstract] [Full-text]
15. Cognitive impairments in multiple system atrophy: MSA-C vs MSA-P.
    Neurology, 70(16): 1390-6. [Abstract] [Full-text]
16. Metabolic abnormalities associated with mild cognitive impairment in Parkinson disease.
    Neurology, 70(16): 1470-7. [Abstract] [Full-text]
17. Globus pallidus dopamine and Parkinson motor subtypes: clinical and brain biochemical correlation.
    Neurology, 70(16): 1403-10. [Abstract] [Full-text]
18. Midbrain iron content in early Parkinson disease: a potential biomarker of disease status.
    Neurology, 70(16): 1411-7. [Abstract] [Full-text]
19. Dissociation of metabolic and neurovascular responses to levodopa in the treatment of Parkinson's disease.
    J Neurosci, 28(16): 4201-9. [Abstract] [Full-text]
20. Genetic association study of synphilin-1 in idiopathic Parkinson's disease.
    BMC Med Genet, 9: 19. [Abstract] [Full-text]
21. Role of autophagy in G2019S-LRRK2-associated neurite shortening in differentiated SH-SY5Y cells.
    J Neurochem, 105(3): 1048-56. [Abstract] [Full-text]
22. Structural effects of Parkinson's disease linked DJ-1 mutations.
    Protein Sci, 17(5): 855-68. [Abstract] [Full-text]

© 2004-2008 Parkinson's Disease Research Today. All Rights Reserved.